SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-003545
Filing Date
2022-03-14
Accepted
2022-03-14 16:22:55
Documents
13
Period of Report
2022-03-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K akya-20220314x8k.htm   iXBRL 8-K 43101
2 EX-99.1 akya-20220314xex99d1.htm EX-99.1 202976
  Complete submission text file 0001558370-22-003545.txt   382970

Data Files

Seq Description Document Type Size
3 EX-101.SCH akya-20220314.xsd EX-101.SCH 3049
4 EX-101.LAB akya-20220314_lab.xml EX-101.LAB 16585
5 EX-101.PRE akya-20220314_pre.xml EX-101.PRE 10461
7 EXTRACTED XBRL INSTANCE DOCUMENT akya-20220314x8k_htm.xml XML 5042
Mailing Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762
Business Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762 855.896.8401
Akoya Biosciences, Inc. (Filer) CIK: 0001711933 (see all company filings)

IRS No.: 475586242 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40344 | Film No.: 22736933
SIC: 3826 Laboratory Analytical Instruments